Chemoinformaics analysis of STIGMASTA-7,22-DIEN-3BETA,4BETA-DIOL
| Molecular Weight | 428.701 | nRot | 5 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 21 |
| Exact Molecular Weight | 428.365 | nRing | 4 |
| Solubility: LogS | -6.468 | nHRing | 0 |
| Solubility: LogP | 6.676 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 82.0401 |
| nHD | 2 | BPOL | 48.1539 |
| QED | 0.474 |
| Synth | 4.884 |
| Natural Product Likeliness | 2.947 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.043 |
| CACO-2 | -4.626 |
| MDCK | 0.00001 |
| BBB | 0.903 |
| PPB | 0.990282 |
| VDSS | 1.161 |
| FU | 0.0147731 |
| CYP1A2-inh | 0.026 |
| CYP1A2-sub | 0.553 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.895 |
| CYP2c9-inh | 0.1 |
| CYP2c9-sub | 0.198 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.666 |
| CYP3a4-inh | 0.311 |
| CYP3a4-sub | 0.635 |
| CL | 15.448 |
| T12 | 0.013 |
| hERG | 0.006 |
| Ames | 0.033 |
| ROA | 0.169 |
| SkinSen | 0.008 |
| Carcinogencity | 0.021 |
| EI | 0.007 |
| Respiratory | 0.703 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.639236 |